Cargando…
SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks
BACKGROUND: Drug repositioning is an emerging approach in pharmaceutical research for identifying novel therapeutic potentials for approved drugs and discover therapies for untreated diseases. Due to its time and cost efficiency, drug repositioning plays an instrumental role in optimizing the drug d...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821180/ https://www.ncbi.nlm.nih.gov/pubmed/33482713 http://dx.doi.org/10.1186/s12859-020-03950-3 |
_version_ | 1783639364279992320 |
---|---|
author | Jarada, Tamer N. Rokne, Jon G. Alhajj, Reda |
author_facet | Jarada, Tamer N. Rokne, Jon G. Alhajj, Reda |
author_sort | Jarada, Tamer N. |
collection | PubMed |
description | BACKGROUND: Drug repositioning is an emerging approach in pharmaceutical research for identifying novel therapeutic potentials for approved drugs and discover therapies for untreated diseases. Due to its time and cost efficiency, drug repositioning plays an instrumental role in optimizing the drug development process compared to the traditional de novo drug discovery process. Advances in the genomics, together with the enormous growth of large-scale publicly available data and the availability of high-performance computing capabilities, have further motivated the development of computational drug repositioning approaches. More recently, the rise of machine learning techniques, together with the availability of powerful computers, has made the area of computational drug repositioning an area of intense activities. RESULTS: In this study, a novel framework SNF-NN based on deep learning is presented, where novel drug-disease interactions are predicted using drug-related similarity information, disease-related similarity information, and known drug-disease interactions. Heterogeneous similarity information related to drugs and disease is fed to the proposed framework in order to predict novel drug-disease interactions. SNF-NN uses similarity selection, similarity network fusion, and a highly tuned novel neural network model to predict new drug-disease interactions. The robustness of SNF-NN is evaluated by comparing its performance with nine baseline machine learning methods. The proposed framework outperforms all baseline methods ([Formula: see text] = 0.867, and [Formula: see text] =0.876) using stratified 10-fold cross-validation. To further demonstrate the reliability and robustness of SNF-NN, two datasets are used to fairly validate the proposed framework’s performance against seven recent state-of-the-art methods for drug-disease interaction prediction. SNF-NN achieves remarkable performance in stratified 10-fold cross-validation with [Formula: see text] ranging from 0.879 to 0.931 and [Formula: see text] from 0.856 to 0.903. Moreover, the efficiency of SNF-NN is verified by validating predicted unknown drug-disease interactions against clinical trials and published studies. CONCLUSION: In conclusion, computational drug repositioning research can significantly benefit from integrating similarity measures in heterogeneous networks and deep learning models for predicting novel drug-disease interactions. The data and implementation of SNF-NN are available at http://pages.cpsc.ucalgary.ca/ tnjarada/snf-nn.php. |
format | Online Article Text |
id | pubmed-7821180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78211802021-01-22 SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks Jarada, Tamer N. Rokne, Jon G. Alhajj, Reda BMC Bioinformatics Research Article BACKGROUND: Drug repositioning is an emerging approach in pharmaceutical research for identifying novel therapeutic potentials for approved drugs and discover therapies for untreated diseases. Due to its time and cost efficiency, drug repositioning plays an instrumental role in optimizing the drug development process compared to the traditional de novo drug discovery process. Advances in the genomics, together with the enormous growth of large-scale publicly available data and the availability of high-performance computing capabilities, have further motivated the development of computational drug repositioning approaches. More recently, the rise of machine learning techniques, together with the availability of powerful computers, has made the area of computational drug repositioning an area of intense activities. RESULTS: In this study, a novel framework SNF-NN based on deep learning is presented, where novel drug-disease interactions are predicted using drug-related similarity information, disease-related similarity information, and known drug-disease interactions. Heterogeneous similarity information related to drugs and disease is fed to the proposed framework in order to predict novel drug-disease interactions. SNF-NN uses similarity selection, similarity network fusion, and a highly tuned novel neural network model to predict new drug-disease interactions. The robustness of SNF-NN is evaluated by comparing its performance with nine baseline machine learning methods. The proposed framework outperforms all baseline methods ([Formula: see text] = 0.867, and [Formula: see text] =0.876) using stratified 10-fold cross-validation. To further demonstrate the reliability and robustness of SNF-NN, two datasets are used to fairly validate the proposed framework’s performance against seven recent state-of-the-art methods for drug-disease interaction prediction. SNF-NN achieves remarkable performance in stratified 10-fold cross-validation with [Formula: see text] ranging from 0.879 to 0.931 and [Formula: see text] from 0.856 to 0.903. Moreover, the efficiency of SNF-NN is verified by validating predicted unknown drug-disease interactions against clinical trials and published studies. CONCLUSION: In conclusion, computational drug repositioning research can significantly benefit from integrating similarity measures in heterogeneous networks and deep learning models for predicting novel drug-disease interactions. The data and implementation of SNF-NN are available at http://pages.cpsc.ucalgary.ca/ tnjarada/snf-nn.php. BioMed Central 2021-01-22 /pmc/articles/PMC7821180/ /pubmed/33482713 http://dx.doi.org/10.1186/s12859-020-03950-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Jarada, Tamer N. Rokne, Jon G. Alhajj, Reda SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks |
title | SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks |
title_full | SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks |
title_fullStr | SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks |
title_full_unstemmed | SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks |
title_short | SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks |
title_sort | snf-nn: computational method to predict drug-disease interactions using similarity network fusion and neural networks |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821180/ https://www.ncbi.nlm.nih.gov/pubmed/33482713 http://dx.doi.org/10.1186/s12859-020-03950-3 |
work_keys_str_mv | AT jaradatamern snfnncomputationalmethodtopredictdrugdiseaseinteractionsusingsimilaritynetworkfusionandneuralnetworks AT roknejong snfnncomputationalmethodtopredictdrugdiseaseinteractionsusingsimilaritynetworkfusionandneuralnetworks AT alhajjreda snfnncomputationalmethodtopredictdrugdiseaseinteractionsusingsimilaritynetworkfusionandneuralnetworks |